XENE EBITDA Margin
Xenon Pharmaceuticals Inc · EBITDA Margin
XENE EBITDA Margin
Latest reported-4791.55%period ending
XENE TTM EBITDA Margin (-7.69% → -4791.55%)
TTM ebitda margin
High-resolution chart · PNG
XENE ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -4,791.5467% | |
| -4,427.9733% | |
| -4,206.6133% | |
| -3,871.4933% | |
| -136,679.5455% | |
| -23,253.7425% | |
| -1,310.4834% | |
| -829.6333% | |
| -410.5751% | |
| -346.7586% | |
| -423.5342% | |
| -333.7028% | |
| -326.7943% | |
| -126.8899% | |
| -88.7645% | |
| -88.1496% | |
| -96.2259% | |
| -258.4238% | |
| -582.1497% | |
| -388.3895% | |
| -701% | |
| -665.6333% | |
| -541.95% | |
| -202,256.25% | |
| -9,418.9286% | |
| -9,033.2203% | |
| -9,975.5627% | |
| -4,234.8733% | |
| -3,415.3659% | |
| -2,167.4056% | |
| -1,328.508% | |
| -450.7091% | |
| -168.3656% | |
| -63.8478% | |
| -53.4313% | |
| -33.4572% | |
| 13.9243% | |
| 17.192% | |
| 41.7483% | |
| 47.4531% | |
| 43.6108% | |
| 40.3916% | |
| 38.0794% | |
| 27.3709% | |
| -7.6919% |